Company attributes
Location
B2X
0
CEO
Pitchbook URL
Legal Name
Lexaria Bioscience Corp.
Number of Employees (Ranges)
1 – 10
Email Address
info@lexariabioscience.com0
Phone Number
+125076564240
Full Address
100-740 McCurdy Rd Kelowna, BC, V1X2P70
CIK Number
Place of Incorporation
DUNS Number
2432044310
IRS Number
202,000,8710
Total Funding Amount (USD)
1,200,000
Latest Funding Round Date
December 20, 2021
Stock Symbol
LEXX0
Exchange
Board of Directors
CFO
NAICS Code
311,9990
CAGE Code
L0LP30
Country
Other attributes
Company Operating Status
Active
Contact Page URL
Previous Name
Lexaria Corp.0
SIC Code
2,8340
Ticker Symbol
LEXX
Lexaria Bioscience Corp. has developed it's DehydraTECHTM technology that promotes healthy administration methods.
Lexaria Bioscience Corp’s ( NASDAQ:LEXX) proprietary drug delivery technology, DehydraTECH™, improves the way active pharmaceutical ingredients (APIs) enter the bloodstream by promoting healthier delivery methods and increasing the effectiveness of fat-soluble active molecules and drugs.
The Company’s technology can be applied to many different drugs and other active ingredients such as vitamins in oral formats including tablets, capsules, oral suspensions – and even foods, beverages and topical preparations.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Further Resources
No Further Resources data yet.
